Advisory Board and Editors Biochemistry
Sonia MR Oliveira
Doctor Sonia Oliveira holds a Licenciatura in Biology (pre-Bologna) and a Master in Cellular and Molecular Biology from the University of Aveiro, where she also specialized in medicinal plants, toxicology, murine models, and spermatogenesis. In 2011 she moved to Australia to work in Reproductive Biological Sciences. She later explored the nerve-cancer connection in Cancer, namely in female cancers, and completed her Ph.D. in Human Physiology ( with a significant component in Medical Biochemistry and Neurophysiology) from the University of Newcastle (Australia) in 2018. She then worked with biomimetic systems and nanotechnology in diabetes and stem cells. She explored multiple methods for primary and secondary cell culture, always with a keen interest in histopathology, cell biology, and rare disorders. Participated in >40 event(s). (Co-)Supervised MSc dissertation(s) and final projects for course completion of LSc/BSc. And works mostly in the area(s) of Natural sciences with emphasis on Molecular and Cellular Biology, and Medical and Health Sciences with emphasis on Neurosciences, Cancer, Reproduction, Toxicology, Biotechnology, and Stem cells. Also has collaborations in Microbiology, Biomaterials, and Communication and Information technologies.
Brenda Oppert
EDUCATION
University of Texas at El Paso (9/75-8/78), B.S. in Biology, 1978
University of Texas at El Paso (1/83-12/86), M.S. in Biology, 1986
Kansas State University (8/86-5/91), Ph.D. in Biochemistry, 1991
PROFESSIONAL
• Research Molecular Biologist (GS-15), CGAHR, Manhattan, KS (4/91-present)
• Adjunct Professor, Department of Entomology, Kansas State University (1/99-present)
Krishna Dev Oruganty
I can best describe myself as a simulation biologist. I am interested in simulating life processes at multiple scales. From the atomic scale to understand protein function to cellular or systems scale to understand physiological processes. My main tool is the computer which I use to analyze, understand and predict biology. Secondary tools are in vitro biochemistry and biophysics experiments that I use to validate my predictions.
Adegboyega K Oyelere
Educational Background: B.Sc. Chemistry (Industrial Option), 1st Class Honors, 1992, University of Ibadan, Nigeria. Ph.D. Organic Chemistry, 1998, Brown University, Providence Rhode Island
Employment History:
July 1998 – Nov. 2001: Postdoctoral Associate and Jane Coffin Childs Postdoctoral Fellow, Dept. of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut.
Nov. 2001 – Jan. 2004: Research Scientist II, Rib-X Pharmaceuticals, Inc.
Jan. 2004 – Aug. 2005: Senior Research Scientist, Rib-X Pharmaceuticals, Inc.
Aug. 2005 – April 2011: Assistant Professor, Chemistry and Biochemistry Georgia Institute of Technology, Atlanta.
Dec. 2007 – Nov. 2009: Blanchard Assistant Professor, Chemistry and Biochemistry Georgia Institute of Technology, Atlanta.
April 2011 – March 2022: Associate Professor, Chemistry and Biochemistry Georgia Institute of Technology, Atlanta.
March 2022 – Present: Professor, Chemistry and Biochemistry Georgia Institute of Technology, Atlanta.
Emanuele Paci
Professor at University of Bologna. From 2004 to 2021 Associate Professor in Computational Biophysics at University of Leeds. From 2001 to 2004, Oberassistent at the Department of Biochemistry, University of Zurich.
Isabel M Palacios
University at Madrid, Spain; PhD at EMBL Germany; Postdoc at the Gurdon Institute, Cambridge, UK; Group Leader as a Royal Society University Research Fellow and currently as a University Senior Research Fellow, Cambridge, UK. Also a Fellow of St John's College, Cambridge, UK
Thiago Parente
Scientist in Public Health at the Laboratory of Functional Genomics and Bioinformatics at the Oswaldo Cruz Institute (IOC, Fiocruz), Rio de Janeiro, Brazil. Scientific coordinator of the Institutional Bioinformatics Platform. CNPq Level 2 Research Productivity Scholar (Genetics). Permanent professor at the Graduate program on Systems and Computational Biology IOC, Fiocruz. Graduated in Biological Sciences - Genetics major - from the Federal University of Rio de Janeiro (2006), with a Master's degree in Cell and Molecular Biology from the IOC (2008) and PhD in Biophysics from UFRJ (2012). Through high performance technologies for DNA sequencing and computational data analysis, I investigate the effects of pollution on fauna, using fish as model organisms, and their responses and genetic adaptations to pollutants, especially those involved in the xenobiotic biotransformation system.
Tanya Parish
Tanya Parish a Principal Investigator in the Center for Global Infectious Disease Research, Seattle Children’s Research Institute and a Professor in the Department of Pediatrics, University of Washington School of Medicine.
Her work focuses on the discovery of new drugs that are effective at curing drug-sensitive and drug-resistant tuberculosis with the added goal of shortening the time it takes to cure disease. This encompasses a range of early stage drug discovery including drug target identification and validation, high throughput screening and medicinal chemistry. In addition, her group works to understand the pathogenic mechanisms and basic biology of the global pathogen Mycobacterium tuberculosis and using this information to inform drug discovery.
Tanya is a microbiologist by training, with a background in mycobacteriology. She received her PhD at the National Institute for Medical Research investigating gene regulation in mycobacteria followed by postdoctoral research at the London School of Hygiene & Tropical Medicine studying several facets of the biology of M. tuberculosis. She previously held an academic post as Professor of Mycobacteriology at Barts and the London School of Medicine and Dentistry, and was a Senior Vice President (Drug Discovery) at the Infectious Disease Research Institue.
Tanya has edited several books on mycobacteria and published numerous papers on the basic biology and genetics of M. tuberculosis.
Santosh K Patnaik
After completing my training as a physician, I enrolled in a Ph.D. program to become a biomedical researcher. My doctoral training, in the broad field of biochemistry, and cell and molecular biology, focused on mechanisms of glycosylation, which is altered in diseases such as cancer and neuromuscular dystrophy. My current primary research focus is on RNA editing, and on microRNAs.
Fabiana Perocchi
Fabiana Perocchi is an Emmy Noether Group Leader at the Helmholtz Zentrum München and Munich University. She trained as a postdoc with Vamsi Mootha at MGH and Harvard Medical School. She has a PhD in Functional Genomics from EMBL (European Molecular Biology Laboratory) and Heidelberg University, with Prof. Lars Steinmetz. Her research seeks to understand the signaling cascades that regulate mitochondrial metabolism and calcium homeostasis and their dysfunctions in neurodegenerative diseases.
Kevin Petrie
I obtained my PhD from the Institute of Cancer Research in London spent a further 10 years there as a postdoctoral fellow and Staff Scientist. I am currently a Lecturer in Molecular Biology at the University of Stirling in Scotland. My principal research interest is translational oncology, with a focus on epigenetics.
Paripok Phitsuwan
Dr. Paripok Phitsuwan is Assistant Professor in the Division of Biochemical Technology at King Mongkut's Univeristy of Technology, Thonburi.
Dr. Phitsuwan's research focuses on biomass conversion and processing, particularly lignin valorization. He is interested in carbohydrate and lignin active enzymes and their applications in biotechnology-relevant industries and environmental remediation.